-
Capricor Therapeutics (NASDAQ:CAPR) Receives Buy Rating from HC Wainwright
来源: Buzz FX / 18 3月 2025 13:36:17 America/New_York
Capricor Therapeutics (NASDAQ:CAPR) Receives Buy Rating from HC Wainwright Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Capricor Therapeutics ( NASDAQ:CAPR - Get Free Report ) 's stock had its "buy" rating
Read more...